Project title: THERAPEUTICS FOR METABOLIC PROBLEMS

Company name : DIALEAN LTD.

TECHNOLOGICAL FIELD
Biotechnology, Pharmaceuticals

KEY WORDS
Metabolic Problems,
Obesity, Cachexia, Metabolic Syndrome

PROJECT SUMMARY
DIALEAN develops therapeutics for metabolic problems and in
particular weight management problems and their complications,
based on proprietary proteins DiaLean discovered.

Cachexia, a progressive wasting syndrome involving involuntary
loss of fat and lean (muscle protein) body mass and frequently
accompanied by anorexia (reduced appetite). It occurs in more
then 50% of cancer patients and patients with chronic or
end-staged diseases such as infections, AIDS, congestive heart
failure, cystic fibrosis, rheumatoid arthritis and Crohn's
disease. Cachexia has a large impact on morbidity and mortality
of patients.
Another severe weight management problem is obesity. The
prevalence of overweight and obesity is increasing worldwide at
an alarming rate in both developing and developed countries.
Overweight and obesity are the underlying causes for the
metabolic syndrome which is defined, in addition to central
obesity, by Atherogenic dyslipidemia (blood fat disorders -
mainly high triglycerides and low HDL cholesterol that foster
plaque buildups in artery walls), Raised blood pressure, Insulin
resistance or glucose intolerance, and proinflammatory state.

Both weight-management problems are so severe that the FDA
fast-track approval process would be applied for these weight
management indications.
Focusing on a growing market of obesity/metabolic syndrome which
is currently estimated at US $20 billion, and the market of
cachexia which is currently estimated at over US $4 billion,
DiaLean is developing novel variants of known proteins that have
already been verified in extensive pre-clinical and early stage
clinical studies. In this way DiaLean avoids most of the basic
research stage and starts with process development toward a
treatment for these weight-management problems.

ENTREPRENEURS
Dr. Liat Mintz - Ph.D.
Mr. Eli Mintz - BSc, MBA
Dr. Natanja Kirschbaum-Slager - Manager

PROJECT STATUS
The project started its second year of activities in the
Incubator.

COOPERATION REQUIRED
Strategic partners and investments.
---------------------------------------------------------------
TEL: 972-3-9067598; 972-52-6686313

Request for more information, about this project.

Note - you have to be registered in this server to request information. If you haven't done so yet, please:
Register in this server and your requests will be forwarded to the developer, who will contact you directly

List of projects that you already requested more information about